Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Implementing newer agents for the management of castrate-resistant prostate cancer: what is known and what is needed?

Published:2014-07-15 Issue:3 Volume:115 Page:364-372
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Mottet Nicolas¹,Clarke Noel²,De Santis Maria³,Zattoni Filiberto⁴,Morote Juan⁵,Joniau Steven⁶

Affiliation:

1. University Hospital; Saint Etienne France

2. The Christie and Salford Royal Hospitals; Manchester UK

3. LBI-ACR & ACR-ITR Vienna, Kaiser Franz Josef-Spital; Vienna Austria

4. University of Padua; Padua Italy

5. Vall d'Hebron Hospital; Barcelona Spain

6. University Hospitals Leuven; Leuven Belgium

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12736/fullpdf

Reference70 articles.

1. Heidenreich A Bastian PJ Bellmunt J Guidelines on prostate cancer 2013 http://www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf

2. New therapeutics to treat castrate-resistant prostate cancer;Acar;ScientificWorldJournal,2013

3. Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome;Manni;J Clin Oncol,1988

4. Importance of continued testicular suppression in hormone-refractory prostate cancer;Taylor;J Clin Oncol,1993

5. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frühe vs. spätere Therapie mit Abirateron plus Prednison bei chemotherapie-naiven, asymptomatischen bis mild symptomatischen Patienten mit metastasiertem CRPC nach Androgendeprivation;Aktuelle Urologie;2020-04-08

2. Longitudinal model–based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer;European Journal of Clinical Pharmacology;2020-01-10

3. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β‐catenin pathway in prostate cancer;Journal of Cellular Biochemistry;2019-02-27

4. Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer;Investigative and Clinical Urology;2019

5. Patients’ Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment;Clinical Therapeutics;2017-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3